OBJECTIVE: To examine the relationship between alcohol, both the amount and type, and cognitive decline in a cohort of Alzheimer's disease (AD) patients. METHODS: A cohort of 360 patients with early AD in New York, Boston, Baltimore and Paris were followed-up biannually for up to 19.28 years. At each visit, the cognitive profile of the patients was assessed using the modified Mini-Mental State Examination (mMMSE), and patients' alcohol intake, including beverage type, was reported by patients' primary caregivers. General estimating equation analysis was used to determine whether baseline alcohol use was associated with the rate of cognitive decline. RESULTS: Heavy drinkers (8 or more alcoholic drinks/week) had a faster cognitive decline, deteriorating 1.849 more points on their mMMSE score annually compared to abstainers (P = 0.001), or 2.444 more points compared to mild-moderate drinkers (1-7 alcoholic drinks/week) (P = 0.008). There was no significant difference when comparing mild-moderate drinkers to abstainers. Increasing standard drinks of hard liquor, but not beer or wine, was also associated with a faster rate of cognitive decline (β = -0.117 P = 0.001). CONCLUSION: Heavy alcohol consumption and more hard liquor are associated with a faster rate of cognitive decline in AD patients, suggesting that they may hasten progression of AD. Our results suggest that alcohol drinking habits might alter the course of AD.
OBJECTIVE: To examine the relationship between alcohol, both the amount and type, and cognitive decline in a cohort of Alzheimer's disease (AD) patients. METHODS: A cohort of 360 patients with early AD in New York, Boston, Baltimore and Paris were followed-up biannually for up to 19.28 years. At each visit, the cognitive profile of the patients was assessed using the modified Mini-Mental State Examination (mMMSE), and patients' alcohol intake, including beverage type, was reported by patients' primary caregivers. General estimating equation analysis was used to determine whether baseline alcohol use was associated with the rate of cognitive decline. RESULTS: Heavy drinkers (8 or more alcoholic drinks/week) had a faster cognitive decline, deteriorating 1.849 more points on their mMMSE score annually compared to abstainers (P = 0.001), or 2.444 more points compared to mild-moderate drinkers (1-7 alcoholic drinks/week) (P = 0.008). There was no significant difference when comparing mild-moderate drinkers to abstainers. Increasing standard drinks of hard liquor, but not beer or wine, was also associated with a faster rate of cognitive decline (β = -0.117 P = 0.001). CONCLUSION: Heavy alcohol consumption and more hard liquor are associated with a faster rate of cognitive decline in ADpatients, suggesting that they may hasten progression of AD. Our results suggest that alcohol drinking habits might alter the course of AD.
Authors: Jyri J Virtaa; Tarja Järvenpää; Kauko Heikkilä; Markus Perola; Markku Koskenvuo; Ismo Räihä; Juha O Rinne; Jaakko Kaprio Journal: J Alzheimers Dis Date: 2010 Impact factor: 4.472
Authors: Annemieke Ruitenberg; John C van Swieten; Jacqueline C M Witteman; Kala M Mehta; Cornelia M van Duijn; Albert Hofman; Monique M B Breteler Journal: Lancet Date: 2002-01-26 Impact factor: 79.321
Authors: Zheng-Ming Ding; Zachary A Rodd; Eric A Engleman; Jason A Bailey; Debomoy K Lahiri; William J McBride Journal: Addict Biol Date: 2012-12-14 Impact factor: 4.280
Authors: Joan Lindsay; Danielle Laurin; René Verreault; Réjean Hébert; Barbara Helliwell; Gerry B Hill; Ian McDowell Journal: Am J Epidemiol Date: 2002-09-01 Impact factor: 4.897
Authors: Simon Zhornitsky; Shefali Chaudhary; Thang M Le; Yu Chen; Sheng Zhang; Stéphane Potvin; Herta H Chao; Christopher H van Dyck; Chiang-Shan R Li Journal: Psychiatry Res Neuroimaging Date: 2021-08-29 Impact factor: 2.376
Authors: Rachel Sayko Adams; Jessica M Ketchum; Risa Nakase-Richardson; Douglas I Katz; John D Corrigan Journal: Am J Phys Med Rehabil Date: 2021-08-01 Impact factor: 3.412
Authors: Sergey Kalinin; Marta González-Prieto; Hannah Scheiblich; Lucia Lisi; Handojo Kusumo; Michael T Heneka; Jose L M Madrigal; Subhash C Pandey; Douglas L Feinstein Journal: J Neuroinflammation Date: 2018-05-14 Impact factor: 8.322